Vapor inhalation exposure to soman in conscious untreated rats: preliminary assessment of neurotoxicity

References

• Aas P, Veiteberg TA, Fonnum F. (1987). Acute and sub-acute inhalation of an organophosphate induce alteration of cholinergic muscarinic receptors. Biochem Pharmacol 36:1261–6
   PubMed Web of Science ®Google Scholar
• Bajgar J. (1997). Differential inhibition of the brain acetylcholinesterase molecular forms following sarin, soman and VX intoxication in laboratory rats. Acta Medica (Hradec Kralove) 40:89–94
   PubMedGoogle Scholar
• Britt JO, Jr. Martin JL, Okerberg CV, Dick EJ. Jr. (2000). Histopathologic changes in the brain, heart, and skeletal muscle of rhesus macaques, ten days after exposure to soman (an organophosphorus nerve agent). Comp Med 50:133–9
   PubMed Web of Science ®Google Scholar
• Dabisch PA, Davis EA, Renner JA, et al. (2008a). Biomarkers of low-level exposure to soman vapor: comparison of fluoride regeneration to acetylcholinesterase inhibition. Inhal Toxicol 20:149–56
   PubMed Web of Science ®Google Scholar
• Dabisch PA, Horsmon MS, Muse WT, et al. (2007). Muscarinic receptor dysfunction induced by exposure to low levels of soman vapor. Toxicol Sci 100:281–9
   PubMed Web of Science ®Google Scholar
• Dabisch PA, Horsmon MS, Taylor JT, et al. (2008b). Gender difference in the miotic potency of soman vapor in rats. Cutan Ocul Toxicol 27:123–33
   PubMed Web of Science ®Google Scholar
• De Araujo Furtado M, Lumley LA, Robison C, et al. (2010). Spontaneous recurrent seizures after status epilepticus induced by soman in Sprague-Dawley rats. Epilepsia 51:1503–10
   PubMed Web of Science ®Google Scholar
• Franz DR, Hilaski R. (1990). Sequence of cardiorespiratory effects of soman altered by route of administration. Toxicol Lett 51:221–5
   PubMed Web of Science ®Google Scholar
• Gupta RC. (2004). Brain regional heterogeneity and toxicological mechanisms of organophosphates and carbamates. Toxicol Mech Methods 14:103–43
   PubMed Web of Science ®Google Scholar
• Gupta RC, Patterson GT, Dettbarn WD. (1987). Biochemical and histochemical alterations following acute soman intoxication in the rat. Toxicol Appl Pharmacol 87:393–402
   PubMed Web of Science ®Google Scholar
• Haigh JR, Lefkowitz LJ, Capacio BR, et al. (2008). Advantages of the WRAIR whole blood cholinesterase assay: comparative analysis to the micro-Ellman, Test-mate ChE, and Michel (DeltapH) assays. Chem Biol Interact 175:417–20
   PubMed Web of Science ®Google Scholar
• Johnson EA, Kan RK. (2010). The acute phase response and soman-induced status epilepticus: temporal, regional and cellular changes in rat brain cytokine concentrations. J Neuroinflammation 7:40
   PubMed Web of Science ®Google Scholar
• Kassa J, Bajgar J. (1998). Changes of acetylcholinesterase activity in various parts of brain following nontreated and treated soman poisoning in rats. Mol Chem Neuropathol 33:175–84
   PubMedGoogle Scholar
• McDonough JH, Jr Clark TR, Slone TW, Jr et al. (1998). Neural lesions in the rat and their relationship to EEG delta activity following seizures induced by the nerve agent soman. Neurotoxicology 19:381–91
   PubMed Web of Science ®Google Scholar
• McLeod CG, Jr. Singer AW, Harrington DG. (1984). Acute neuropathology in soman poisoned rats. Neurotoxicology 5:53–7
   PubMed Web of Science ®Google Scholar
• Mioduszewski R, Manthei J, Way R, et al. (2002). Interaction of exposure concentration and duration in determining acute toxic effects of sarin vapor in rats. Toxicol Sci 66:176–84
   PubMed Web of Science ®Google Scholar
• Muse WT, Thomson S, Crouse C, Matson K. (2006). Generation, sampling, and analysis for low-level GB (Sarin) and GF (Cyclosarin) vapor for inhalation toxicology studies. Inhal Toxicol 18:1101–8
   PubMed Web of Science ®Google Scholar
• Myhrer T, Enger S, Aas P. (2004). Cognitive side effects in rats caused by pharmacological agents used to prevent soman-induced lethality. Eur J Pharmacol 483:271–9
   PubMed Web of Science ®Google Scholar
• Niven AS, Roop SA. (2004). Inhalational exposure to nerve agents. Respir Care Clin N Am 10:59–74
   PubMedGoogle Scholar
• Perkins MW, Wong B, Rodriguez A, et al. (2015). Measurement of various respiratory dynamics parameters following acute inhalational exposure to soman vapor in conscious rats. Inhal Toxicol 1–8
   PubMedGoogle Scholar
• Perkins MW, Wong B, Rodriguez A, et al. (2013). Inhalation toxicity of soman vapor in non-anesthetized rats: a preliminary assessment of inhaled bronchodilator or steroid therapy. Chem Biol Interact 206:452–61
   PubMed Web of Science ®Google Scholar
• Petras JM. (1981). Soman neurotoxicity. Fundam Appl Toxicol 1:242
   PubMedGoogle Scholar
• Petras JM. (1994). Neurology and neuropathology of Soman-induced brain injury: an overview. J Exp Anal Behav 61:319–29
   PubMed Web of Science ®Google Scholar
• Phalen RF. (1976). Inhalation exposure of animals. Environ Health Perspect 16:17–24
   PubMed Web of Science ®Google Scholar
• Shafferman A, Ordentlich A, Barak D, et al. (1997). Aging of somanyl-acetylcholinesterase adducts: facts and models. Biochem J 324:996–8
   PubMed Web of Science ®Google Scholar
• Shih TM. (1982). Time course effects of soman on acetylcholine and choline levels in six discrete areas of the rat brain. Psychopharmacology (Berl) 78:170–5
   PubMed Web of Science ®Google Scholar
• Shih TM, Kan RK, McDonough JH. (2005). In vivo cholinesterase inhibitory specificity of organophosphorus nerve agents. Chem Biol Interact 157158:293–303
   Web of Science ®Google Scholar
• Shih TM, McDonough JH. Jr (1997). Neurochemical mechanisms in soman-induced seizures. J Appl Toxicol 17:255–64
   PubMed Web of Science ®Google Scholar
• Sidell FR. (1996). Chemical agent terrorism. Ann Emerg Med 28:223–4
   PubMed Web of Science ®Google Scholar
• Sidell FR, Borak J. (1992). Chemical warfare agents: II. Nerve agents. Ann Emerg Med 21:865–71
   PubMed Web of Science ®Google Scholar
• Skovira JW, Shih TM, McDonough JH. (2012). Neuropharmacological specificity of brain structures involved in soman-induced seizures. Neurotoxicology 33:463–8
   PubMed Web of Science ®Google Scholar
• Sungur M, Guven M. (2001). Intensive care management of organophosphate insecticide poisoning. Crit Care 5:211–15
   PubMed Web of Science ®Google Scholar
• Talbot BG, Anderson DR, Harris LW, et al. (1988). comparison of in vivo and in vitro rates of aging of soman-inhibited erythrocyte acetylcholinesterase in different animal species. Drug Chem Toxicol 11:289–305
   PubMed Web of Science ®Google Scholar
• Taysse L, Daulon S, Delamanche S, et al. (2006). Protection against soman-induced neuropathology and respiratory failure: a comparison of the efficacy of diazepam and avizafone in guinea pig. Toxicology 225:25–35
   PubMed Web of Science ®Google Scholar
• Wasterlain CG, Chen JW. (2008). Mechanistic and pharmacologic aspects of status epilepticus and its treatment with new antiepileptic drugs. Epilepsia 49:63–73
   PubMed Web of Science ®Google Scholar
• Wong B, Perkins MW, Santos MD, et al. (2013). Development of a model for nerve agent inhalation in conscious rats. Toxicol Mech Methods 23:537–47
   PubMed Web of Science ®Google Scholar
• Worek F, Thiermann H, Szinicz L, Eyer P. (2004). Kinetic analysis of interactions between human acetylcholinesterase, structurally different organophosphorus compounds and oximes. Biochem Pharmacol 68:2237–48
   PubMed Web of Science ®Google Scholar